Clinical trial Recruiting at 2 sites Interventional Ages 40 and up

Comparing over-the-counter and prescription hearing aids for better hearing access

Official title: Effectiveness Trial to Examine the Emerging Service Delivery Models for Over-the-Counter (OTC) Hearing Aids

Run by University of Colorado, Denver · NCT06689865 · Data updated 2026-11-12

This study tests whether over-the-counter hearing aids work as well as prescription ones for people with mild to moderate hearing loss and looks at how they affect hearing experiences and costs.

More Hearing Loss trials

Quick facts

Study typeInterventional
Ages40 Years and up
SexAll
Enrollment280 (estimated)
SponsorUniversity of Colorado, Denver
Academic / other
Locations2 sites (Aurora, Colorado and 1 other locations)
StatusRecruiting
StartedNovember 13, 2024
Main results expectedDecember 31, 2028
Study endsMarch 31, 2029
Registry record updatedNovember 19, 2024
Trial IDNCT06689865 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 40 and older with mild to moderate sensorineural hearing loss who have not used hearing aids for more than three months.

Probably not a fit

Patients with severe hearing loss, middle ear disorders, or neurological conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This research evaluates the effectiveness of various service delivery models for over-the-counter (OTC) hearing aids compared to traditional prescription hearing aids fitted by specialists. The study will assess user experiences, cognitive impacts, and brain activity related to hearing among individuals with mild to moderate hearing loss. It will also explore preferences for different hearing aid options and analyze the costs associated with four distinct service models. The findings aim to inform healthcare providers and policymakers about the practical implications of OTC hearing aids.

Why it matters

Potential benefit: If successful, this study could enhance accessibility to hearing aids, improving the quality of life for individuals with hearing loss.

How similar studies have gone: Other studies have shown promise in evaluating OTC hearing aids, but this specific approach comparing multiple service delivery models is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult onset, bilateral, mild-to-moderate sensorineural hearing loss documented by audiological evaluation
* Aged 40 years or older
* No previous HA experience greater than 3 months
* Able to read and understand patient education materials
* Willing to be randomized to one of the four groups, and
* Owns a smartphone

Exclusion Criteria:

* Hearing loss that is too severe for OTC HAs
* Middle ear disorders or conductive pathology present
* Asymmetrical hearing loss
* Diagnosed neurological condition such as dementia or Parkinson's disease or a score lower than 25 on the MOCA
* Non-English speaking as it may impact the ability to complete our test battery

Where it's running

  • University of Colorado School of Medicine
    Aurora, Colorado, United States
    Recruiting
  • University of Colorado Boulder
    Boulder, Colorado, United States
    Recruiting

Study contacts

  • Principal investigator: Vinaya Manchaiah, AuD, MBA, PhD — University of Colorado, Denver
  • Study coordinator: Research Service Professional
  • Email: ihat@cuanschutz.edu
  • Phone: 303-724-8465

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.